Skip to content

Exelixis EXEL Other Working Capital

Other Working Capital at other companies

Eli Lilly logo
Eli LillyLLY
-$175M-137%
Incyte logo
IncyteINCY
-$12.77M-141%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$7.63M+115%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$306K-1,557%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$0-100%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's other working capital?
Exelixis (EXEL) reported other working capital of $2.02M in Q1 2026.
How has Exelixis's other working capital changed year-over-year?
Exelixis's other working capital decreased by 57.8% year-over-year, from $4.79M to $2.02M.
What is the long-term trend for Exelixis's other working capital?
Over 2 years (2022 to 2024), Exelixis's other working capital has grown at a 409.5% compound annual growth rate (CAGR), from $525K to $13.63M.
What does other working capital mean?
Net changes in miscellaneous short-term operating assets and liabilities.
How do you interpret other working capital?
Large fluctuations may indicate operational inefficiencies or timing issues in vendor payments and collections.
How does other working capital compare across companies?
Varies widely based on the complexity of the company's supply chain and operational structure.